期刊
LETTERS IN APPLIED MICROBIOLOGY
卷 73, 期 6, 页码 718-724出版社
OXFORD UNIV PRESS
DOI: 10.1111/lam.13560
关键词
antimicrobials; diseases; pharmaceuticals; resistance; yeasts
资金
- Deanship of Scientific Research, The University of Jordan, Amman-Jordan
The study found that silver nanoparticles enhance the antifungal ability of fluconazole, reduce the concentration of fluconazole, and provide a promising method for the treatment of Candida glabrata infections.
Resistance to azole antifungal agents is a challenging limitation in Candida glabrata treatment. It is associated with decreased intracellular concentrations of antifungal agents as a result of overexpression of efflux pumps on the cellular plasma membranes. This work evaluates the potential of silver nanoparticles (AgNPs) to reverse the resistance of fungal cells to fluconazole. Silver nanoparticles were prepared using wet chemical method and characterised by UV-Vis spectrophotometry, dynamic light scattering, and zeta potential. Broth microdilution and pour plates methods were used to study the anticandidal activity using two C. glabrata fluconazole-resistant strains (DSY565 and CBS138) known to overexpress active efflux pumps, and a standard fluconazole sensitive strain ATCC 22553. Silver nanoparticles-fluconazole combinations decreased concentrations of fluconazole substantially without compromising the activity. These findings suggest that AgNPs enhance the efficacy of fluconazole and offer a promising application in therapy of C. glabrata infections.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据